You are here: Industry Insights > biotechs

News List

China unveils final rules for Nasdaq-style high-tech board fiercepharma
March 11, 2019
China’s securities authorities released final rules for the country’s new Nasdaq-style high-tech board, which could compete with Hong Kong, S.A.R., China and New York for listing of China-based tech companies, including biotechs.
Novo Holdings invests in three more AMR biotechs pharmaphorum
January 23, 2019
Novo Holdings’ REPAIR Impact Fund, which helps fund companies tackling antimicrobial resistance (AMR), has announced three new investments....
Atlas Venture raises $250M for later-stage investments fiercebiotech
January 04, 2019
Atlas Venture has raised $250 million to invest in existing portfolio companies. The fund, the first of its kind operated by Atlas, will enable the VC shop to support its startups through series B and beyond......
Junshi Biosciences aims for $414M Hong Kong, S.A.R., China IPO: Reuters fiercebiotech
December 28, 2018
China’s Junshi Biosciences may follow in compatriot Innovent Biologics’ footsteps as it tees up to raise $414 million in its Hong Kong, S.A.R., China IPO....
Few biopharma buyouts in quiet third quarter evaluate
October 22, 2018
The $6.6bn of M&A deals announced by drug makers in third quarter of 2018 marks the slowest three-month period since 2013.
Pipeline Concerns: Four Biotechs to Keep Your Eye On biospace
April 12, 2018
If a pipeline is not well-secured, the leaks can weaken the intrinsic value of the business.
3 Small Biotechs Big Drugmakers are Making Googly Eyes At biospace
January 30, 2018
2018 just might be the best time to be a small biotech -- and own shares of small biotech stocks -- than ever before.
5 Biotechs Drawing Buyout Buzz in 2018 biospace
January 25, 2018
Biotech stocks have been on a rise for about the last year.
3 Biotechs That Have Doubled Investors' Money in Less Than a Year biospace
January 24, 2018
Having a stock double in value is a good thing. Having it double—or more—in a year is even better. Keith Speights, writing for The Motley Fool, looks at three healthcare stocks that have doubled in less than 12 months.
Can 2018 Possibly Rival 2017's Biotechs Record Venture Capital Splurge? biospace
January 11, 2018
It was a banner year for the stock market, with the S&P 500 gaining 19.4%, while the iShares Nasdaq Biotechnology Index ETF (IBB) clocked in with an even more impressive 20.9% gain.

Previous page 1 2 Next page